Report - 761058Orig1s000 - Food and Drug Administration · 1 CLINCIAL PHARMACOLOGY REVIEW BLA 761058 Submission Date: October 27, 2016 Proposed Brand Name: Cyltezo Nonproprietary Name: Adalimumab-adbm

Please pass captcha verification before submit form